Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1974 Jun;36(6):588–596. doi: 10.1136/hrt.36.6.588

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.

P A Majid, M K Meeran, M E Benaim, B Sharma, S H Taylor
PMCID: PMC458864  PMID: 4850484

Full text

PDF
588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aenishänslin W., Pestalozzi-Kerpel J., Dubach U. C., Imhof P. R., Turri M. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators. Eur J Clin Pharmacol. 1972 Jun;4(3):177–181. doi: 10.1007/BF00561142. [DOI] [PubMed] [Google Scholar]
  2. Beilin L. J., Juel-Jensen B. E. Alpha and beta adrenergic blockade in hypertension. Lancet. 1972 May 6;1(7758):979–982. doi: 10.1016/s0140-6736(72)91154-3. [DOI] [PubMed] [Google Scholar]
  3. Evans J. G., Prior I. A. Experience with the random-zero sphygmomanometer. Br J Prev Soc Med. 1970 Feb;24(1):10–15. doi: 10.1136/jech.24.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FREIS E. D. Hemodynamics of hypertension. Physiol Rev. 1960 Jan;40:27–54. doi: 10.1152/physrev.1960.40.1.27. [DOI] [PubMed] [Google Scholar]
  5. GARROW J. S. ZERO-MUDDLER FOR UNPREJUDICED SPHYGMOMANOMETRY. Lancet. 1963 Dec 7;2(7319):1205–1205. doi: 10.1016/s0140-6736(63)92929-5. [DOI] [PubMed] [Google Scholar]
  6. Gilmore E., Weil J., Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970 Mar 5;282(10):521–527. doi: 10.1056/NEJM197003052821001. [DOI] [PubMed] [Google Scholar]
  7. Gould L., Zahir M., Ettinger S. Phentolamine and cardiovascular performance. Br Heart J. 1969 Mar;31(2):154–162. doi: 10.1136/hrt.31.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HANDLEY C. A., MOYER J. H. Unilateral renal adrenergic blockade and the renal response to vasopressor agents and to hemorrhage. J Pharmacol Exp Ther. 1954 Sep;112(1):1–7. [PubMed] [Google Scholar]
  9. MOYER J. H., CAPLOVITZ C. The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects. Am Heart J. 1953 Apr;45(4):602–610. doi: 10.1016/0002-8703(53)90170-7. [DOI] [PubMed] [Google Scholar]
  10. Moran N. C. Adrenergic receptors, drugs, and the cardiovascular system. (1). Mod Concepts Cardiovasc Dis. 1966 Jun;35(6):93–97. [PubMed] [Google Scholar]
  11. NICKERSON M. Mechanism of the prolonged adrenergic blockade produced by haloalkylamines. Arch Int Pharmacodyn Ther. 1962 Nov 1;140:237–250. [PubMed] [Google Scholar]
  12. Prichard B. N., Gillam P. M. Treatment of hypertension with propranolol. Br Med J. 1969 Jan 4;1(5635):7–16. doi: 10.1136/bmj.1.5635.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sannerstedt R., Stenberg J., Vedin A., Wilhelmsson C., Werkö L. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. Am J Cardiol. 1972 May;29(5):718–723. doi: 10.1016/0002-9149(72)90176-2. [DOI] [PubMed] [Google Scholar]
  14. TAYLOR S. H., DONALD K. W., BISHOP J. M. Circulatory studies in hypertensive patients at rest and during exercise, with a note on the Starling relationship in the left ventricle in essential hypertension. Clin Sci. 1957 May;16(2):351–376. [PubMed] [Google Scholar]
  15. TAYLOR S. H., SUTHERLAND G. R., MACKENZIE G. J., STAUNTON H. P., DONALD K. W. THE CIRCULATORY EFFECTS OF INTRAVENOUS PHENTOLAMINE IN MAN. Circulation. 1965 May;31:741–754. doi: 10.1161/01.cir.31.5.741. [DOI] [PubMed] [Google Scholar]
  16. TAYLOR S. H., SUTHERLAND G. R., MACKENZIE G. J., STAUNTON H. P., DONALD K. W. THE CIRCULATORY EFFECTS OF PHENTOLAMINE IN MAN WITH PARTICULAR RESPECT TO CHANGES IN FOREARM BLOOD FLOW. Clin Sci. 1965 Apr;28:265–284. [PubMed] [Google Scholar]
  17. Wright B. M., Dore C. F. A random-zero sphygmomanometer. Lancet. 1970 Feb 14;1(7642):337–338. doi: 10.1016/s0140-6736(70)90709-9. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES